Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.

Seyed-Omar Zaraei, Abduelmula R Abduelkarem, Hanan S Anbar, Sara Kobeissi, Miami Mohammad, Aya Ossama, Mohammed I El-Gamal

Journal: European journal of medicinal chemistry 2019;179():257-271

PMID: 31255926

Abstract

In the present article, we reviewed the sulfamate-containing compounds reported as bioactive molecules. The possible molecular targets of sulfamate derivatives include steroid sulfatase enzyme, carbonic anhydrases, acyl transferase, and others. Sulfamate derivatives can help treat hormone-dependent tumors including breast, prostate, and endometrial cancers, Binge eating disorder, migraine, glaucoma, weight loss, and epilepsy. Sulfamate derivatives can act also as calcium sensing receptor agonists and can aid in osteoporosis. Furthermore, acyl sulfamate derivatives can act as antibacterial agents against Gram-positive bacteria. A recent study revealed a new side effect of topiramate, a sulfamate-containing compound, which is sialolithiasis. The structural and biological characteristics of the reviewed compounds are presented in detail.

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Address: Sharjah Institute for Medical Research, University of Sharjah, Sharjah, 27272, United Arab Emirates.; College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates.; Faculty of Pharmacy, University of Mansoura, Mansoura, 35516, Egypt.; Sharjah Institute for Medical Research, University of Sharjah, Sharjah, 27272, United Arab Emirates; College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates; Faculty of Pharmacy, University of Mansoura, Mansoura, 35516, Egypt. Electronic address: [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.